Healthcare of Today Signs Agreement and Plan of Merger with Organ Transport Systems

BURBANK, CA-May 17, 2010-Healthcare of Today, Inc. announces that it has signed a definitive Agreement and Plan of Merger with Organ Transport Systems, Inc. (OTS), a biomedical company engaged in developing, patenting and commercializing portable preservation and transport technology for human organs. The Agreement and Plan of Merger has been unanimously approved by the OTS board of directors and will be voted on by OTS shareholders at a Special Shareholder Meeting to be held June 2, 2010 at 9:00 AM CDT at the headquarters of OTS in Frisco, Texas.

Organ Transport Systems, Inc. (www.organtransportsystems.com) aims to increase the utilization of donor organs through its breakthrough preservation technology. In published preclinical studies, OTS' LifeCradle™ device and perfusion solutions have significantly increased the time for which donor organs can be utilized and enhanced the health and viability of organs. OTS's LifeCradle™ is patented in the U.S. with additional patents either granted or pending internationally. The company is preparing for a European clinical study with transplant centers in Pamplona, Spain and Paris, France to be followed by an FDA clinical trial in the United States at 15 of the major cardiac transplant centers.

The company's technological breakthrough has come at a time when the rapidly growing organ demand has far exceeded the donor organ supply. According to the United Network for Organ Sharing (UNOS), a single donor can donate up to eight solid organs. In spite of the need for organs, the average organ utilization rate is low, for example, only 27% of donated hearts are transplanted and only 9% of lungs, while the U.S. waiting list for organ has grown to over 100,000 people

CEO of Organ Transport Systems Michael B. Holder says, "OTS is very excited about our plans to join the HOTI team; we share a commitment to improving the delivery of healthcare as well as better patient outcomes. A business collaboration between HOTI and OTS would be beneficial for our shareholders by offering numerous opportunities to leverage additional corporate, financial, and marketing resources to strengthen our business, and through that, create incremental shareholder value. "

Healthcare of Today CEO Henry Jan says, "Every eleven minutes someone is added to the organ waiting list, yet the majority of those people never get organs. An efficient healthcare system cannot allow this to happen if better alternatives exist. We are proud to partner with OTS to fill in this gap and change the paradigm of donor organ utilization."

OTS's Board of Directors includes Tommy G. Thompson, former U.S. Secretary of Health and Human Services and initial leader of the Donor Organ Breakthrough Collaborative.